# The Medicines (Products for Human Use) (Fees) Regulations 2016, Paragraph 35A: Early Access to Medicines Scheme fees


The fee payable under regulation 12(1)(a) in connection with an application submitted under the Early Access to Medicines Scheme of a kind described in column 1 of the following table is the fee specified in the corresponding entry in column 2 of that table.
Fees for Early Access to Medicines Scheme applications
Column 1
Column 2
Kind of Application
Fee payable
1. Promising Innovative Medicine (PIM) designation
£4,852
2. EAMS scientific opinion for new medicinal products
£31,214
3. Renewal of an EAMS scientific opinion for new chemical or biological medicinal products
£15,607
4. EAMS scientific opinion for new indications
£10,115
5. Renewal of an EAMS scientific opinion for new indications
£5,057

---
Source: https://www.legislation.gov.uk/uksi/2016/190/schedule/2/paragraph/35A (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-2/paragraph-35A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.